Osteopontin–CD44v6 Interaction Mediates Calcium Deposition via Phospho-Akt in Valve Interstitial Cells From Patients With Noncalcified Aortic Valve Sclerosis

Author:

Poggio Paolo1,Branchetti Emanuela1,Grau Juan B.1,Lai Eric K.1,Gorman Robert C.1,Gorman Joseph H.1,Sacks Michael S.1,Bavaria Joseph E.1,Ferrari Giovanni1

Affiliation:

1. From the Department of Surgery, Perelman School of Medicine at University of Pennsylvania, Philadelphia (P.P., E.B., J.B.G., E.K.L., R.C.G., J.H.G., J.E.B., G.F.); Centro Cardiologico Monzino IRCCS, Milan, Italy (P.P.); Columbia University–Valley Heart Center, Ridgewood, NJ (J.B.G.); and Department of Biomedical Engineering, University of Texas at Austin (M.S.S.).

Abstract

Objective— The activation of valve interstitial cells (VICs) toward an osteogenic phenotype characterizes aortic valve sclerosis, the early asymptomatic phase of calcific aortic valve disease. Osteopontin is a phosphorylated acidic glycoprotein that accumulates within the aortic leaflets and labels VIC activation even in noncalcified asymptomatic patients. Despite this, osteopontin protects VICs against in vitro calcification. Here, we hypothesize that the specific interaction of osteopontin with CD44v6, and the related intracellular pathway, prevents calcium deposition in human-derived VICs from patients with aortic valve sclerosis. Approach and Results— On informed consent, 23 patients and 4 controls were enrolled through the cardiac surgery and heart transplant programs. Human aortic valves and VICs were tested for osteogenic transdifferentiation, ex vivo and in vitro. Osteopontin–CD44 interaction was analyzed using proximity ligation assay and the signaling pathways investigated. A murine model based on angiotensin II infusion was used to mimic early pathological remodeling of the aortic valves. We report osteopontin–CD44 functional interaction as a hallmark of early stages of calcific aortic valve disease. We demonstrated that osteopontin–CD44 interaction mediates calcium deposition via phospho-Akt in VICs from patients with noncalcified aortic valve sclerosis. Finally, microdissection analysis of murine valves shows increased cusp thickness in angiotensin II-treated mice versus saline infused along with colocalization of osteopontin and CD44 as seen in human lesions. Conclusions— Here, we unveil a specific protein–protein association and intracellular signaling mechanisms of osteopontin. Understanding the molecular mechanisms of early VIC activation and calcium deposition in asymptomatic stage of calcific aortic valve disease could open new prospective for diagnosis and therapeutic intervention.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference75 articles.

1. Molecular and Cellular Aspects of Calcific Aortic Valve Disease

2. Spectrum of Calcific Aortic Valve Disease

3. Management of asymptomatic valvular aortic stenosis.;Freeman RV;Indian Heart J,2002

4. Aortic Stenosis

5. Insights into the use of biomarkers in calcific aortic valve disease.;Beckmann E;J Heart Valve Dis,2010

Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Valvular Interstitial Cells: Physiology, Isolation, and Culture;Technologies in Cell Culture - A Journey From Basics to Advanced Applications [Working Title];2023-09-18

2. Atheroprotective Aspects of Heat Shock Proteins;International Journal of Molecular Sciences;2023-07-21

3. Osteopontin in Pulmonary Hypertension;Biomedicines;2023-05-07

4. Calcific aortic valve disease: mechanisms, prevention and treatment;Nature Reviews Cardiology;2023-02-24

5. The Role of Macrophages in the Pathogenesis of Atherosclerosis;Cells;2023-02-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3